Showing results (1-10 of 249) with videos related to
Sort By:
Pageof 25
Circulation|September 1, 1991
The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroximeD S Berman, H Kiat, J MaddahiRadiologic Clinics of North America|July 1, 1993
Myocardial perfusion imaging using technetium-99m radiopharmaceuticalsH Kiat, D S Berman, J MaddahiThe American Journal of Cardiology|May 21, 1991
Myocardial perfusion imaging with technetium-99m-labeled agentsJ Maddahi, H Kiat, D S BermanCardiology Clinics|May 1, 1994
State-of-the-art myocardial perfusion imagingJ Maddahi, E Rodrigues, D S Berman, et al.The American Journal of Cardiology|July 18, 1989
Radionuclide imaging of myocardial perfusion and viability in assessment of acute myocardial infarctionD S Berman, H Kiat, J Maddahi, et al.Seminars in Nuclear Medicine|July 1, 1991
Technetium 99m sestamibi in the assessment of chronic coronary artery diseaseD S Berman, H Kiat, K Van Train, et al.Journal of the American College of Cardiology|May 1, 1991
A new approach to the assessment of tomographic thallium-201 scintigraphy in patients with left bundle branch blockL Matzer, H Kiat, J D Friedman, et al.The American Journal of Cardiology|October 16, 1990
Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viabilityD S Berman, H Kiat, K F Van Train, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1990
Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: a multicenter trialK F Van Train, J Maddahi, D S Berman, et al.Journal of the American College of Cardiology|December 1, 1988
Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viabilityH Kiat, D S Berman, J Maddahi, et al.Pageof 25